Therapies / Drug / Pharmaceuticals / Pharmaceutical / Drugs / Boston / Boston blog main / Boston top stories / National blog main / New York blog main / San Francisco blog main / San Francisco top stories / American Society of Hematology / BioMarin Pharmaceutical / clinical trials / emicizumab / FDA / fitusiran / Hemlibra / hemophilia / hemophilia A / hemophilia B / Hemophilia Federation of America / John Maraganore / Leerink Partners / Life Sciences / Paul Matteis / RNA Interference / Sanofi / transthyretin amyloidosis

In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward

Posted on: Dec 15, 2017   |   Posted by: Biotech Mag

In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward

The FDA has cleared Alnylam Pharmaceuticals to resume testing of an experimental hemophilia drug after instituting a variety of measures meant to manage the possible risks of...

Continue reading ...